Regeneron Pharmaceuticals Contracts & Agreements

221 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Regeneron Pharmaceuticals, Inc. Common and Class A Stock Registered Under Section 12 of the Exchange Act
Regeneron Pharmaceuticals
Biotechnology
2025
Amendment Agreement to License and Collaboration Agreement between Regeneron Pharmaceuticals, Inc. and Bayer Healthcare LLC (May 7, 2012)
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2025
Amendment No. 3 to Master Agreement between Regeneron Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc.
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2024
Amendment No. 2 to Master Agreement between Regeneron Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc.
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2024
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for Executive Officers
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2024
Regeneron Pharmaceuticals, Inc. Restricted Stock Agreement for Executive Officers under 2014 Long-Term Incentive Plan
Equity Distribution Agreements
Regeneron Pharmaceuticals
Biotechnology
2024
First Amendment to Amended and Restated License and Collaboration Agreement between Regeneron Pharmaceuticals, Inc. and Aventis Pharmaceuticals Inc.
License Agreements
Regeneron Pharmaceuticals
Biotechnology
2023
Amendment No. 1 to Master Agreement between Regeneron Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc.
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2023
Waiver and Consent to Amended and Restated Employment Agreement between Regeneron Pharmaceuticals, Inc. and Leonard S. Schleifer, M.D., Ph.D.
Waiver Agreements
Regeneron Pharmaceuticals
Biotechnology
2023
First Amendment to Regeneron Pharmaceuticals, Inc. Cash Incentive Bonus Plan
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
2023
Third Amended and Restated Participation Agreement among Old Saw Mill Holdings LLC, BA Leasing BSC, LLC, Bank of America, N.A., and Rent Assignees (March 27, 2023)
Participation Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2023
Third Amended and Restated Lease and Remedies Agreement between Old Saw Mill Holdings LLC and BA Leasing BSC, LLC (March 27, 2023)
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2023
Third Amended and Restated Guaranty Agreement by Regeneron Pharmaceuticals, Inc. and Subsidiaries, March 27, 2023
Guaranty Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2023
Credit Agreement among Regeneron Pharmaceuticals, Inc., Subsidiaries, and JPMorgan Chase Bank, N.A. (December 19, 2022)
Credit Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2022
Modification No. 02 to MCDC Base Agreement Between Regeneron Pharmaceuticals, Inc. and ATI
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 03 to Project Agreement No. 01 between Regeneron Pharmaceuticals, Inc. and Advanced Technology International for Large-Scale Manufacturing of COVID-19 Antibodies
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 04 to Project Agreement No. 01 between Regeneron Pharmaceuticals, Inc. and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 06 to Project Agreement No. 01 between Regeneron Pharmaceuticals, Inc. and Advanced Technology International (MCDC)
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Amendment P00001 to Supply Agreement between Regeneron Pharmaceuticals, Inc. and U.S. Army Contracting Command
Supply Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Second Modification to Supply Agreement Between Regeneron Pharmaceuticals, Inc. and U.S. Army Contracting Command
Supply Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Amendment P00003 to Supply Agreement Between Regeneron Pharmaceuticals, Inc. and U.S. Army Contracting Command
Supply Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Amendment P00007 to Supply Agreement between Regeneron Pharmaceuticals, Inc. and U.S. Army Contracting Command
Supply Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 5 to Project Agreement No. 01 (MCDC2008-005) between Regeneron Pharmaceuticals, Inc. and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Amended and Restated Immuno-Oncology License and Collaboration Agreement between Sanofi Biotechnology SAS and Regeneron Pharmaceuticals, Inc.
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2022
Fifth Amendment to Amended and Restated License and Collaboration Agreement between Sanofi and Regeneron
License Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 01 to MCDC Base Agreement Between Regeneron Pharmaceuticals, Inc. and ATI
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 05 to Project Agreement No. 01 (MCDC2008-005) between Regeneron Pharmaceuticals, Inc. and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Amendment P00006 to Supply Agreement between Regeneron Pharmaceuticals, Inc. and U.S. Army Contracting Command
Supply Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Second Amended and Restated Participation Agreement among Old Saw Mill Holdings LLC, BA Leasing BSC, LLC, Bank of America, N.A., and Rent Assignees (March 2, 2022)
Participation Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2022
Second Amended and Restated Lease and Remedies Agreement between Old Saw Mill Holdings LLC and BA Leasing BSC, LLC (March 2, 2022)
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2022
Second Amended and Restated Guaranty Agreement by Regeneron Pharmaceuticals, Inc. and Subsidiaries, March 2, 2022
Guaranty Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2022
Fourth Amendment to Amended and Restated License and Collaboration Agreement between Sanofi and Regeneron Pharmaceuticals, Inc.
License Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Amendment No. 1 to Credit Agreement among Regeneron Pharmaceuticals, Inc., Affiliates, and JPMorgan Chase Bank, N.A.
Credit Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2022
First Amendment to Immuno-Oncology License and Collaboration Agreement between Sanofi Biotechnology SAS and Regeneron Pharmaceuticals, Inc.
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
First Amendment to Amended and Restated Participation Agreement among Old Saw Mill Holdings LLC, Regeneron Pharmaceuticals, Inc., BA Leasing BSC, LLC, Bank of America, N.A., and...
Participation Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Amendment P00004 to Supply Agreement between Regeneron Pharmaceuticals, Inc. and U.S. Army Contracting Command
Supply Agreements
Regeneron Pharmaceuticals
Biotechnology
2021
Amendment P00005 to Supply Agreement between Regeneron Pharmaceuticals, Inc. and U.S. Army Contracting Command
Supply Agreements
Regeneron Pharmaceuticals
Biotechnology
2021
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement with P. Roy Vagelos
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2021
Regeneron Pharmaceuticals, Inc. Restricted Stock Agreement for Executive Officers under 2014 Long-Term Incentive Plan
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
2021
Regeneron Pharmaceuticals, Inc. Restricted Stock Unit Agreement with Employee (P. Roy Vagelos)
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
2021
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for Non-Employee Directors
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2021
Regeneron Pharmaceuticals, Inc. Restricted Stock Unit Agreement for Non-Employee Directors
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
2021
Regeneron Pharmaceuticals, Inc. Performance Restricted Stock Unit Agreement
Compensation Agreements
Regeneron Pharmaceuticals
Biotechnology
2021
Project Agreement for Large-Scale Manufacturing of Antibodies Directed to SARS-CoV-2 between Advanced Technology International and Regeneron Pharmaceuticals, Inc.
Development Agreements
Regeneron Pharmaceuticals
Biotechnology
2021
Modification No. 01 to Project Agreement No. 01 (MCDC2008-005) between Regeneron Pharmaceuticals, Inc. and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2021
Modification No. 02 to Project Agreement No. 01 between Regeneron Pharmaceuticals, Inc. and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2021
Base Agreement Between Advanced Technology International and Regeneron Pharmaceuticals, Inc. for Medical CBRN Defense Consortium Participation
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2020
Project Agreement for Large-Scale Manufacturing of Antibodies Directed to SARS-CoV-2 between Advanced Technology International and Regeneron Pharmaceuticals, Inc.
Development Agreements
Regeneron Pharmaceuticals
Biotechnology
2020
License Agreement among Regeneron Pharmaceuticals, F. Hoffmann-La Roche Ltd, and Genentech, Inc. (August 18, 2020)
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Underwriting Agreement for $2 Billion Senior Notes Offering by Regeneron Pharmaceuticals, Inc. and Underwriters
Underwriting Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Indenture Agreement between Regeneron Pharmaceuticals, Inc. and U.S. Bank National Association, dated August 12, 2020
Indenture Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
First Supplemental Indenture to Indenture for Senior Notes between Regeneron Pharmaceuticals, Inc. and U.S. Bank National Association (August 12, 2020)
Indenture Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Amendment No. 1 to Credit Agreement between Regeneron Pharmaceuticals, Inc. and Goldman Sachs Bank USA
Credit Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Third Amendment to Amended and Restated License and Collaboration Agreement between Sanofi and Regeneron
License Agreements
Regeneron Pharmaceuticals
Biotechnology
2020
Praluent Cross License and Commercialization Agreement between Sanofi Biotechnology SAS and Regeneron Pharmaceuticals, Inc.
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Regeneron Pharmaceuticals, Inc. Underwriting Agreement for Sale of Common Stock with BofA Securities, Goldman Sachs, Sanofi, and Aventisub LLC (May 26, 2020)
Underwriting Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Stock Repurchase Agreement between Regeneron Pharmaceuticals, Inc. and Sanofi dated May 25, 2020
Repurchase Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Amendment to Investor Agreement between Regeneron Pharmaceuticals, Inc. and Sanofi (May 25, 2020)
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2020
Credit Agreement among Regeneron Pharmaceuticals, Inc., Lenders, and Goldman Sachs Bank USA (May 25, 2020)
Credit Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Description of Regeneron Pharmaceuticals, Inc. Common Stock and Registration Rights Agreement with Sanofi
Registration Rights Agreements
Regeneron Pharmaceuticals
Biotechnology
2020
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for Executive Officers
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for Employee (Time-Based Vesting)
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Regeneron Pharmaceuticals, Inc. Restricted Stock Agreement for Executive Officers under 2014 Long-Term Incentive Plan
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
2020
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for Non-Employee Directors
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Regeneron Pharmaceuticals, Inc. Restricted Stock Unit Agreement for Non-Employee Directors under 2014 LTIP
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
2020
Regeneron Pharmaceuticals, Inc. Performance Restricted Stock Unit Agreement under 2014 LTIP
Compensation Agreements
Regeneron Pharmaceuticals
Biotechnology
2020
Second Amendment Agreement to License and Collaboration Agreement between Regeneron Ireland DAC and Bayer Healthcare LLC
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2020
Investor Agreement between Regeneron Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc. dated April 8, 2019
Investor Rights Agreements
Regeneron Pharmaceuticals
Biotechnology
MA
2019
Stock Purchase Agreement between Regeneron Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc. dated April 8, 2019
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
MA
2019
Master Collaboration Agreement between Alnylam Pharmaceuticals, Inc. and Regeneron Pharmaceuticals, Inc. (April 8, 2019)
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2019
Co-Co Collaboration Agreement between Alnylam Pharmaceuticals, Inc. and Regeneron Pharmaceuticals, Inc.
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2019
License Agreement between Alnylam Pharmaceuticals, Inc. and Regeneron Pharmaceuticals, Inc.
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2019
Amended and Restated Guaranty Agreement among Regeneron Pharmaceuticals, Inc., Subsidiary Guarantors, and Bank of America, N.A. (as Administrative Agent)
Guaranty Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2019
Amended and Restated Participation Agreement among Old Saw Mill Holdings LLC, BA Leasing BSC, LLC, Bank of America, N.A., and Lenders (May 2, 2019)
Participation Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2019
Amended and Restated Lease and Remedies Agreement between Old Saw Mill Holdings LLC and BA Leasing BSC, LLC (Regeneron 2017 Lease Financing)
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2019
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for Executive Officers
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2019
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement with P. Roy Vagelos
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2019
Regeneron Pharmaceuticals, Inc. Restricted Stock Agreement for Executive Officers under 2014 Long Term Incentive Plan
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
2019
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for Non-Employee Directors
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2019
Regeneron Pharmaceuticals, Inc. Restricted Stock Unit Agreement for Non-Employee Directors under 2014 LTIP
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
2019
Amended and Restated Immuno-Oncology Discovery and Development Agreement between Sanofi Biotechnology SAS and Regeneron Pharmaceuticals, Inc.
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2019
Retirement Agreement Between Regeneron Healthcare Solutions, Inc. and Robert J. Terifay
Retirement Agreements
Regeneron Pharmaceuticals
Biotechnology
2018
Letter Agreement for Limited Waiver and Amendment among Regeneron Pharmaceuticals, Inc., Sanofi, and Affiliates
Waiver Agreements
Regeneron Pharmaceuticals
Biotechnology
2018
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for Executive Officers under 2014 LTIP
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2018
Regeneron Pharmaceuticals, Inc. Incentive Stock Option Agreement for Executive Officers
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2018
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for P. Roy Vagelos
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2018
Regeneron Pharmaceuticals, Inc. Incentive Stock Option Agreement for P. Roy Vagelos
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2018
Regeneron Pharmaceuticals, Inc. Restricted Stock Award Agreement for Executive Officers under 2014 Long-Term Incentive Plan
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
2018
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for Non-Employee Directors
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2018
Termination Agreement for Warrant Transaction between Goldman Sachs & Co. and Regeneron Pharmaceuticals, Inc.
Termination Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2017
Warrant Transaction Termination Agreement between Citibank, N.A. and Regeneron Pharmaceuticals, Inc.
Termination Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2017
Warrant Transaction Termination Agreement between Credit Suisse Capital LLC and Regeneron Pharmaceuticals, Inc.
Termination Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2017
Termination Agreement for Warrant Transaction between Morgan Stanley & Co. International plc and Regeneron Pharmaceuticals, Inc.
Termination Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2017
Second Amendment to Warrant Transaction Agreement between Citibank, N.A. and Regeneron Pharmaceuticals, Inc.
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2016
ANG2 License and Collaboration Agreement between Bayer Healthcare LLC and Regeneron Pharmaceuticals, Inc. (March 23, 2016)
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2016
Regeneron Pharmaceuticals, Inc. Incentive Stock Option Agreement for P. Roy Vagelos
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2016
Regeneron Pharmaceuticals, Inc. Incentive Stock Option Agreement for Employee Time-Vesting Awards
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2015
Immuno-Oncology Discovery and Development Agreement between Sanofi Biotechnology SAS and Regeneron Pharmaceuticals, Inc.
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2015
Immuno-Oncology License and Collaboration Agreement between Sanofi Biotechnology SAS and Regeneron Pharmaceuticals, Inc.
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2015
Amendment No. 1 to Amended and Restated Discovery and Preclinical Development Agreement between Sanofi Biotechnology SAS and Regeneron Pharmaceuticals, Inc.
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2015
Amendment No. 2 to Amended and Restated License and Collaboration Agreement between Sanofi and Regeneron Pharmaceuticals, Inc.
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2015
Second Amendment to Warrant Transaction Between Morgan Stanley & Co. International plc and Regeneron Pharmaceuticals, Inc.
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2015
Seventeenth Amendment to Lease Agreement between BMR-Landmark at Eastview LLC and Regeneron Pharmaceuticals, Inc.
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
2015
Collaboration Agreement between Regeneron Ireland and Mitsubishi Tanabe Pharma Corporation (Fasinumab Anti-NGF Antibody)
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
HI
2015
Tenth Amendment to Lease Agreement between BMR-Landmark at Eastview LLC and Regeneron Pharmaceuticals, Inc.
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
2015
Fourteenth Amendment to Lease Agreement between BMR-Landmark at Eastview LLC and Regeneron Pharmaceuticals, Inc.
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
2015
Fifteenth Amendment to Lease Agreement between BMR-Landmark at Eastview LLC and Regeneron Pharmaceuticals, Inc.
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
2015
Sixteenth Amendment to Lease Agreement between BMR-Landmark at Eastview LLC and Regeneron Pharmaceuticals, Inc.
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
2015
First Amendment to Mt. Pleasant Lease between BMR-Landmark at Eastview LLC and Regeneron Pharmaceuticals, Inc.
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
2015
Regeneron Pharmaceuticals, Inc. Cash Incentive Bonus Plan
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2015
Amended and Restated Collaboration Agreement between Sanofi-Aventis US, LLC and Regeneron Pharmaceuticals, Inc. (February 23, 2015)
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2015
Amendment to Warrant Agreement between Citibank, N.A. and Regeneron Pharmaceuticals, Inc. (May 13, 2014)
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2014
Amendment to Warrant Agreement between Credit Suisse Capital LLC and Regeneron Pharmaceuticals, Inc. (May 14, 2014)
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2014
Amendment to Warrant Agreement between Goldman, Sachs & Co. and Regeneron Pharmaceuticals, Inc. (May 15, 2014)
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2014
Amendment to Warrant Agreement between Morgan Stanley & Co. International plc and Regeneron Pharmaceuticals, Inc. (May 16, 2014)
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2014
Regeneron Pharmaceuticals, Inc. Incentive Stock Option Agreement for Employees under 2014 Long-Term Incentive Plan
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2014
Regeneron Pharmaceuticals, Inc. Restricted Stock Award Agreement under 2014 Long-Term Incentive Plan
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
2014
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for Non-Employee Directors
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2014
Amendment No. 1 to Regeneron Pharmaceuticals, Inc. Second Amended and Restated 2000 Long-Term Incentive Plan
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
2014
Amended and Restated Investor Agreement among Sanofi, Affiliates, and Regeneron Pharmaceuticals, Inc. (January 11, 2014)
Investor Rights Agreements
Regeneron Pharmaceuticals
Biotechnology
DE
2014
Mt. Pleasant Lease Agreement between BMR-Landmark at Eastview LLC and Regeneron Pharmaceuticals, Inc.
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2013
Eleventh Amendment to Lease Agreement between BMR-Landmark at Eastview LLC and Regeneron Pharmaceuticals, Inc.
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
2013
Twelfth Amendment to Lease Agreement between BMR-Landmark at Eastview LLC and Regeneron Pharmaceuticals, Inc.
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2013
Thirteenth Amendment to Lease Agreement between BMR-Landmark at Eastview LLC and Regeneron Pharmaceuticals, Inc.
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
2013
First Amendment to Amended and Restated License and Collaboration Agreement between Regeneron Pharmaceuticals, Inc. and Aventis Pharmaceuticals Inc. (Sanofi)
License Agreements
Regeneron Pharmaceuticals
Biotechnology
2013
Letter Agreement Regarding PDGF Products Between Regeneron Pharmaceuticals, Inc. and Aventis Pharmaceuticals Inc. (Sanofi)
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2013
Amended and Restated Non-Exclusive License and Settlement Agreement between Genentech, Inc. and Regeneron Pharmaceuticals, Inc.
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2013
Non-Exclusive License and Settlement Agreement among Genentech, Regeneron, and Sanofi (May 17, 2013)
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2013
Settlement Agreement Among Bayer, Regeneron, and Genentech Regarding Patent Litigation Over Eylea
Settlement Agreements
Regeneron Pharmaceuticals
Biotechnology
2013
Amendment Agreement to License and Collaboration Agreement between Regeneron Pharmaceuticals, Inc. and Bayer Healthcare LLC (May 7, 2012)
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2012
Non-Exclusive License and Partial Settlement Agreement between Genentech, Inc. and Regeneron Pharmaceuticals, Inc.
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2012
Eighth Amendment to Lease Agreement between BMR-Landmark at Eastview LLC and Regeneron Pharmaceuticals, Inc.
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
2011
Ninth Amendment to Lease Agreement between BMR-Landmark at Eastview LLC and Regeneron Pharmaceuticals, Inc.
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
2011
Purchase Agreement for 1.875% Convertible Senior Notes Due 2016 between Regeneron Pharmaceuticals, Inc. and Goldman, Sachs & Co.
Purchase Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2011
Master Terms and Conditions for Convertible Bond Hedging Transactions between Goldman, Sachs & Co. and Regeneron Pharmaceuticals, Inc.
Financing Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2011
Master Terms and Conditions for Convertible Bond Hedging Transactions between Citibank, N.A. and Regeneron Pharmaceuticals, Inc.
Financing Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2011
Master Terms and Conditions for Convertible Bond Hedging Transactions between Credit Suisse International and Regeneron Pharmaceuticals, Inc.
Financing Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2011
Master Terms and Conditions for Convertible Bond Hedging Transactions between Morgan Stanley & Co. International plc and Regeneron Pharmaceuticals, Inc.
Financing Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2011
Regeneron Pharmaceuticals, Inc. Non-Qualified Performance-Based Stock Option Agreement
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2011
Seventh Amendment to Lease Agreement between BMR-Landmark at Eastview LLC and Regeneron Pharmaceuticals, Inc.
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
2011
Amendment to Non-Exclusive License and Material Transfer Agreement between Astellas Pharma Inc. and Regeneron Pharmaceuticals, Inc.
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2010
Underwriting Agreement between Regeneron Pharmaceuticals, Inc. and Citigroup Global Markets Inc. dated October 7, 2010
Underwriting Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2010
Sixth Amendment to Lease Agreement between BMR-Landmark at Eastview LLC and Regeneron Pharmaceuticals, Inc.
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
2010
Amended and Restated Discovery and Preclinical Development Agreement between Aventis Pharmaceuticals Inc. and Regeneron Pharmaceuticals, Inc.
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2010
Amended and Restated License and Collaboration Agreement among Aventis Pharmaceuticals Inc., Sanofi-Aventis Amerique du Nord, and Regeneron Pharmaceuticals, Inc.
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2010
IL-1 Antibody Termination Agreement between Novartis Pharma AG, Novartis Pharmaceuticals Corporation, and Regeneron Pharmaceuticals, Inc. (June 8, 2009)
Termination Agreements
Regeneron Pharmaceuticals
Biotechnology
NJ
2009
TRAP-2 Termination Agreement between Novartis Pharma AG, Novartis Pharmaceuticals Corporation, and Regeneron Pharmaceuticals, Inc. (June 8, 2009)
Termination Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2009
Regeneron Pharmaceuticals, Inc. Stock Option Agreement for Time Vesting under 2000 Long-Term Incentive Plan
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2009
Third Amendment to Lease Agreement between BMR-Landmark at Eastview LLC and Regeneron Pharmaceuticals, Inc.
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2009
Regeneron Pharmaceuticals, Inc. Change in Control Severance Plan (As Amended and Restated, Effective November 14, 2008)
Change of Control Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2009
Second Amendment to Lease Agreement between BMR-Landmark at Eastview LLC and Regeneron Pharmaceuticals, Inc.
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
2008
Regeneron Pharmaceuticals, Inc. Form of Common Stock Certificate
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
2008
Amended and Restated Non-Exclusive License Agreement between Cellectis and Regeneron Pharmaceuticals, Inc.
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2008
Subscription Agreement between Cellectis S.A. and Regeneron Pharmaceuticals, Inc. dated July 1, 2008
Subscription Agreements
Regeneron Pharmaceuticals
Biotechnology
2008
Regeneron Pharmaceuticals, Inc. Amended and Restated 2000 Long-Term Incentive Plan
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2008
Discovery and Preclinical Development Agreement between Aventis Pharmaceuticals Inc. and Regeneron Pharmaceuticals, Inc. (2007)
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2008
License and Collaboration Agreement among Aventis Pharmaceuticals Inc., Sanofi-Aventis Amerique du Nord, and Regeneron Pharmaceuticals, Inc. (November 28, 2007)
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2008
Stock Purchase Agreement among Sanofi-Aventis Amérique du Nord, Sanofi-Aventis US LLC, and Regeneron Pharmaceuticals, Inc. (November 28, 2007)
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2008
First Amendment to Lease Agreement between BMR-Landmark at Eastview LLC and Regeneron Pharmaceuticals, Inc.
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
2007
Non-Exclusive License and Material Transfer Agreement between Astellas Pharma Inc. and Regeneron Pharmaceuticals, Inc.
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2007
Non-Exclusive License and Material Transfer Agreement between AstraZeneca UK Limited and Regeneron Pharmaceuticals, Inc.
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2007
Underwriting Agreement between Regeneron Pharmaceuticals, Inc. and Morgan Stanley & Co. Incorporated (November 13, 2006)
Underwriting Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2006
License and Collaboration Agreement between Bayer HealthCare LLC and Regeneron Pharmaceuticals, Inc. (October 18, 2006)
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2006
Third Amendment to Collaboration Agreement between Regeneron Pharmaceuticals, Inc. and Aventis Pharmaceuticals Inc.
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2006
Fourth Amendment to Collaboration Agreement between Regeneron Pharmaceuticals, Inc. and Sanofi-Aventis U.S., LLC (January 31, 2006)
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2006
Regeneron Pharmaceuticals, Inc. Change in Control Severance Plan (Effective February 1, 2006)
Change of Control Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2006
Amendment and Agreement between Regeneron Pharmaceuticals, Inc. and The Procter & Gamble Company (June 30, 2005)
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2005
Amendment No. 1 to Manufacturing Agreement between Merck & Co., Inc. and Regeneron Pharmaceuticals, Inc.
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2005
Amendment No. 2 to Manufacturing Agreement between Merck & Co., Inc. and Regeneron Pharmaceuticals, Inc.
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2005
Amendment No. 3 to Manufacturing Agreement between Merck & Co., Inc. and Regeneron Pharmaceuticals, Inc.
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2005
Amendment No. 4 to Manufacturing Agreement between Merck & Co., Inc. and Regeneron Pharmaceuticals, Inc.
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2005
First Amendment to Collaboration Agreement between Regeneron Pharmaceuticals, Inc. and Aventis Pharmaceuticals Inc.
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2005
Second Amendment to Collaboration Agreement between Regeneron Pharmaceuticals, Inc. and Aventis Pharmaceuticals Inc.
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2005
Regeneron Pharmaceuticals, Inc. Restricted Stock Award Agreement under 2000 Long-Term Incentive Plan
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
2004
Amendment No. 3 to Regeneron Pharmaceuticals, Inc. 2000 Long-Term Incentive Plan
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
2004
Collaboration Agreement between Aventis Pharmaceuticals Inc. and Regeneron Pharmaceuticals, Inc. (September 5, 2003)
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2003
Stock Purchase Agreement between Aventis Pharmaceuticals Inc. and Regeneron Pharmaceuticals, Inc. dated September 5, 2003
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2003
Non-Exclusive Patent License Agreement between Merck & Co., Inc. and Regeneron Pharmaceuticals, Inc.
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NJ
2003
Collaboration, License and Option Agreement between Novartis Pharma AG, Novartis Pharmaceuticals Corporation, and Regeneron Pharmaceuticals, Inc.
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2003
Stock Purchase Agreement between Novartis Pharma AG and Regeneron Pharmaceuticals, Inc. dated March 28, 2003
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2003
Registration Rights Agreement between Novartis Pharma AG and Regeneron Pharmaceuticals, Inc. dated March 28, 2003
Registration Rights Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2003
Amendment No. 1 to Regeneron Pharmaceuticals, Inc. 2000 Long-Term Incentive Plan
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
2003
Amendment No. 2 to Regeneron Pharmaceuticals, Inc. 2000 Long-Term Incentive Plan
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
2003
Employment Agreement between Regeneron Pharmaceuticals, Inc. and Leonard S. Schleifer, M.D., Ph.D. (President and CEO)
Employment Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2003
Focused Collaboration Agreement between The Procter & Gamble Company and Regeneron Pharmaceuticals, Inc.
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
DE
2002
IL-1 License Agreement among Regeneron Pharmaceuticals, Immunex Corporation, and Amgen Inc. dated June 26, 2002
License Agreements
Regeneron Pharmaceuticals
Biotechnology
DE
2002
Regeneron Pharmaceuticals, Inc. 2000 Long-Term Incentive Plan
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2002
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for Executive Officers
Compensation Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2021
Third Amendment to Warrant Transaction Agreement between Citibank, N.A. and Regeneron Pharmaceuticals, Inc.
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2017
Consent and Amendment No. 1 Memorandum to Credit Agreement among Regeneron Pharmaceuticals, Inc., JPMorgan Chase Bank, N.A., and Lenders
Regeneron Pharmaceuticals
Biotechnology
2017
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement with P. Roy Vagelos
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2016
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for Non-Employee Directors
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2016
Fourth Amendment to Warrant Transaction Agreement between Credit Suisse Capital LLC and Regeneron Pharmaceuticals, Inc.
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2016
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for Time-Based Vesting (2014 Long-Term Incentive Plan)
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2015
Regeneron Pharmaceuticals, Inc. Restricted Stock Award Agreement under 2014 Long-Term Incentive Plan
Equity Distribution Agreements
Regeneron Pharmaceuticals
Biotechnology
2015
Third Amendment to Warrant Transaction Agreement between Goldman, Sachs & Co. and Regeneron Pharmaceuticals, Inc.
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2015
Restated Amendment Agreement Between Regeneron Pharmaceuticals, Inc. and Bayer Healthcare LLC (May 7, 2012)
Regeneron Pharmaceuticals
Biotechnology
2015
Second Amendment to Warrant Transaction Agreement between Goldman, Sachs & Co. and Regeneron Pharmaceuticals, Inc.
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2015
Second Amendment to Warrant Transaction Agreement between Credit Suisse Capital LLC and Regeneron Pharmaceuticals, Inc.
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2015
Third Amendment to Warrant Transaction Agreement between Credit Suisse Capital LLC and Regeneron Pharmaceuticals, Inc.
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2015
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for Time-Based Vesting (2014 Long-Term Incentive Plan)
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2014
Regeneron Pharmaceuticals, Inc. Employment Offer Letter to Robert Landry (Senior Vice President of Finance, CFO)
Employment Agreements
Regeneron Pharmaceuticals
Biotechnology
2013
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for Non-Employee Directors
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2012
Indenture for 1.875% Convertible Senior Notes Due 2016 between Regeneron Pharmaceuticals, Inc. and Wells Fargo Bank, N.A.
Indenture Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2011
Regeneron Pharmaceuticals, Inc. 1.875% Convertible Senior Note Due 2016 (Form Note)
Note Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2011
Master Terms and Conditions for Base Warrants between Regeneron Pharmaceuticals, Inc. and Goldman, Sachs & Co.
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2011
Master Terms and Conditions for Base Warrants between Regeneron Pharmaceuticals, Inc. and Citibank, N.A.
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2011
Master Terms and Conditions for Base Warrants between Regeneron Pharmaceuticals, Inc. and Credit Suisse International
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2011
Master Terms and Conditions for Base Additional Warrants between Regeneron Pharmaceuticals, Inc. and Morgan Stanley & Co. International plc
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2011
Regeneron Pharmaceuticals, Inc. Restricted Stock Award Agreement under 2000 Long-Term Incentive Plan
Equity Distribution Agreements
Regeneron Pharmaceuticals
Biotechnology
2011
First Amendment to December 20, 2007 Investor Agreement by and among sanofi-aventis, Sanofi US, Aventis, sanofi-aventis Amérique du Nord, and Regeneron Pharmaceuticals, Inc.
Investor Rights Agreements
Regeneron Pharmaceuticals
Biotechnology
2010
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for Performance Vesting Awards
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2009
Amended and Restated Employment Agreement between Regeneron Pharmaceuticals, Inc. and Leonard S. Schleifer, M.D., Ph.D., dated November 14, 2008
Employment Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2009
Investor Agreement among Sanofi-Aventis, Affiliates, and Regeneron Pharmaceuticals, Inc. (December 20, 2007)
Investor Rights Agreements
Regeneron Pharmaceuticals
Biotechnology
DE
2008
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for Directors and Executive Officers
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2005
Regeneron Pharmaceuticals, Inc. Non-Qualified Stock Option Agreement for Executive Officers (Excluding Named Executive Officers)
Equity Distribution Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2005
Amendment No. 5 to Manufacturing Agreement between Merck & Co., Inc. and Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals
Biotechnology
2005
Employment Agreement between Regeneron Pharmaceuticals, Inc. and P. Roy Vagelos, M.D.
Employment Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2005
Regeneron Pharmaceuticals, Inc. Form of Option Agreement and Notice of Grant for Executive Officers (Excluding Named Executive Officers)
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2004
Regeneron Pharmaceuticals, Inc. Option Agreement for Directors and Named Executive Officers under 2000 Long-Term Incentive Plan
Equity Distribution Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2004
Certificate of Amendment to Certificate of Incorporation of Regeneron Pharmaceuticals, Inc.
Articles of Amendment
Regeneron Pharmaceuticals
Biotechnology
2002